{"id":"W4412166794","doi":"10.1017/cjn.2025.10194","title":"P.010 Interim efficacy and safety results from the ongoing phase 3 CHAMPION-NMOSD trial of ravulizumab in adults with AQP4-Ab+ NMOSD","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Burnaby Hospital","funders":"","keywords":"Interim; Champion; Medicine; Phase (matter); Interim analysis; Internal medicine; Clinical trial; Physics; Political science; Quantum mechanics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000953,0.0003295929,0.0004884779,0.0001386275,0.0002590735,0.0006559942,0.0003407554,0.00051142,0.02660094],"category_scores_gemma":[0.002007276,0.000127808,0.0004766617,0.0002091687,0.000252162,0.0003709194,0.0002525599,0.001489509,0.002803332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003031974,"about_ca_system_score_gemma":0.0006571349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000343248,"about_ca_topic_score_gemma":0.0006871743,"domain_scores_codex":[0.9995621,0.0001920253,0.00003258543,0.00004903852,0.00008813719,0.00007612595],"domain_scores_gemma":[0.9985626,0.000491799,0.0002907178,0.00008400435,0.0002268756,0.000344024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4570133,0.005445006,0.03073294,0.00206517,0.002370938,0.0006415317,0.0001829326,0.001667756,0.0198698,0.0010821,0.1751201,0.3038084],"study_design_scores_gemma":[0.3866454,0.186786,0.2634579,0.0005131011,0.003832377,0.001860865,0.0001500607,0.005825981,0.01385341,0.003236718,0.133758,0.00008016254],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8251992,0.01521552,0.003827304,0.008443341,0.001697853,0.003567768,0.03909768,0.0008431703,0.1021081],"genre_scores_gemma":[0.9471099,0.001721791,0.003333771,0.002507702,0.001059733,0.002519685,0.01858486,0.0001262549,0.02303629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02660094,"threshold_uncertainty_score":0.08898896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01940605391406251,"score_gpt":0.2785694262419415,"score_spread":0.259163372327879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}